PRELUDE CAPITAL MANAGEMENT, LLC - FULCRUM THERAPEUTICS INC ownership

FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 62 filers reported holding FULCRUM THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of FULCRUM THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$174,220
+372.6%
28,100
+151.5%
0.01%
+500.0%
Q2 2023$36,864
-66.8%
11,171
+83.9%
0.00%
-66.7%
Q2 2020$111,0006,0730.01%
Other shareholders
FULCRUM THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
TRV GP III, LLC 3,962,202$70,091,00017.54%
TRV GP IV, LLC 2,343,154$41,450,00011.92%
ACUTA CAPITAL PARTNERS, LLC 200,000$3,538,0001.49%
HighVista Strategies LLC 89,963$1,591,0001.27%
Logos Global Management LP 685,000$12,118,0001.25%
Monashee Investment Management LLC 273,045$4,830,0001.19%
RTW INVESTMENTS, LP 3,866,872$68,405,0001.00%
Parkman Healthcare Partners LLC 250,106$4,424,0000.98%
Deep Track Capital, LP 750,000$13,268,0000.94%
Darwin Global Management, Ltd. 317,428$5,615,0000.86%
View complete list of FULCRUM THERAPEUTICS INC shareholders